İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2025

EVALUATION OF EXPERIENCED CLINICAL EVENTS IN POMPE DISEASE BASED ON REAL-LIFE DATA

Neuropediatrics

YÖKSİS OpenAlex SJR Q2 JCR Q3 Atıf 0 Yüzdelik 55.0% FWCI 0.0
Yıl
2025
ISSN
0174-304X
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

Abstract Pompe disease is a rare lysosomal storage disorder with a wide clinical spectrum ranging from infantile-onset Pompe disease (IOPD) with early severe cardiomyopathy to late-onset Pompe disease (LOPD) with progressive muscle weakness. This study aimed to evaluate clinical features, genotype–phenotype correlations, treatment outcomes, and significant events in a real-life pediatric cohort of Pompe patients. We retrospectively analyzed 30 pediatric patients diagnosed with Pompe disease (27 IOPD, 3 LOPD). Demographic, clinical, biochemical, genetic, and radiologic data were collected. Recurrent clinical events were assessed using the Andersen-Gill extension of the Cox model to evaluate the effect of enzyme replacement therapy (ERT). The median age at diagnosis was 5 (range 20 days to 80 months) months, and consanguinity was present in 83% of cases. IOPD cases predominantly showed hypotonia and cardiac involvement, whereas LOPD cases were asymptomatic or mildly symptomatic, with delayed motor development and increased CK levels. Novel GAA mutations were identified in seven patients. ERT was administered to 24 IOPD patients, leading to improved cardiac function and prolonged survival. Event incidence was significantly lower in the ERT group (HR = 0.06, p < 0.005), despite a longer follow-up. However, 56% of patients—all with IOPD—died during follow-up. Non-muscular findings such as neurogenic bladder in 6.6% (2/30), sensorineural hearing loss in 13.3% (4/30), and white matter abnormalities in 40.9% (9/21) were also documented. This real-life evidence reinforces the central role of early, individualized ERT and comprehensive multidisciplinary care in altering the natural course of Pompe disease.

Konular

  • Lysosomal Storage Disorders Research
  • Glycogen Storage Diseases and Myoclonus
  • Whipple's Disease and Interleukins

Birincil konu Lysosomal Storage Disorders Research

Yazarlar

  1. FEHİME ERDEM KARAPINAR
  2. HAVVA YAZICI
  3. MERVE YOLDAŞ ÇELİK
  4. AYŞE YÜKSEL YANBOLU
  5. CENK ERASLAN
  6. Asude Alpman
  7. AYÇA AYKUT
  8. EBRU CANDA EGE ÜNİVERSİTESİ
  9. ZÜLAL ÜLGER TUTAR
  10. SEMA KALKAN UÇAR
  11. REŞİT ERTÜRK LEVENT
  12. ESER YILDIRIM SÖZMEN
  13. MAHMUT ÇOKER